Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy

Neurosurgery
E H ElowitzA D Chanana

Abstract

The success of boron neutron capture therapy depends on the safety and specificity of the boron delivery agent. As a preface to clinical boron neutron capture therapy of glioblastoma multiforme, a biodistribution study of intravenous p-boronophenylalanine (BPA) in patients undergoing craniotomy for resection of glioblastoma was performed. Varying doses of intravenously administered BPA-fructose (130-250 mg BPA per kilogram of body weight) were given to patients 2 to 3 hours prior to the start of craniotomy for either suspected or known glioblastoma multiforme. Blood samples were collected over a 48-hour period for boron assay. At surgery, multiple samples of tumor, brain, and scalp were obtained for boron and histological analysis. Seventeen patients were studied; all but one had glioblastoma multiforme. No adverse effects from the BPA infusions were noted. The boron concentration in the blood reached a maximum at the end of the BPA infusion and was proportional to the administered dose of BPA. Normal brain concentrations of boron generally were equal to or less than that in blood. Tumor-blood boron ratios were highly variable: 1.6 +/- 0.8 (mean +/- standard deviation; n = 187; range, 0.3-3.5). The observed heterogeneity of BPA...Continue Reading

References

Jul 1, 1989·Pigment Cell Research·Y MoriH Kakihana
Sep 1, 1994·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·G M MorrisA Bywaters
Oct 15, 1994·International Journal of Radiation Oncology, Biology, Physics·J A CoderreH B Liu
Mar 30, 1994·International Journal of Radiation Oncology, Biology, Physics·H Hatanaka, Y Nakagawa
Mar 30, 1994·International Journal of Radiation Oncology, Biology, Physics·J L MalleschW A Stening
May 1, 1997·Journal of Neuro-oncology·P R GavinJ A Coderre

❮ Previous
Next ❯

Citations

Oct 8, 2003·Technology in Cancer Research & Treatment·Jeffrey A CoderreW S Kiger
Aug 24, 2007·Acta Neurologica Scandinavica·B H-StenstamA Brun
Feb 26, 2008·Acta Neurologica Scandinavica·L PellettieriK Sköld
Apr 5, 2002·Physics in Medicine and Biology·Päivi RyynänenSauli Savolainen
Apr 27, 2013·Future Medicinal Chemistry·Zhu Yinghuai, Narayan S Hosmane
May 17, 2003·Journal of Neuro-oncology·Jacek CapalaRoger Henriksson
Aug 12, 2004·Acta Oncologica·Per M Munck af RosenschöldBertil R R Persson
Jul 8, 2005·Pharmacy World & Science : PWS·Catharina M van RijArie C van Loenen
Jun 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rolf F BarthThomas E Blue
Jul 8, 2015·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Rolf F Barth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved